Cureus
https://www.researchpad.co/tools/openurl?pubtype=&doi=10.7759/cureus.16307&title=Relapsed/Refractory Non-Hodgkin Lymphoma: Engineering T-Cells to Express Chimeric Antigen Receptors (CARs), a Salvage?&author=&keyword=[{keywordId=52, uniqueName=immunotherapy, name=Immunotherapy, contentId=265612}, {keywordId=99, uniqueName=t-cells, name=T cells, contentId=265612}, {keywordId=15203, uniqueName=car-t-cell-therapy, name=CAR-T cell therapy, contentId=265612}, {keywordId=57082, uniqueName=non-hodgkin-lymphoma, name=Non-Hodgkin lymphoma, contentId=265612}, {keywordId=173600, uniqueName=cd19, name=CD19, contentId=265612}, {keywordId=327467, uniqueName=chimeric-antigen-receptors, last=true, name=chimeric antigen receptors, contentId=265612}],[{keywordId=52, uniqueName=immunotherapy, name=Immunotherapy, contentId=265612}, {keywordId=99, uniqueName=t-cells, name=T cells, contentId=265612}, {keywordId=15203, uniqueName=car-t-cell-therapy, name=CAR-T cell therapy, contentId=265612}, {keywordId=57082, uniqueName=non-hodgkin-lymphoma, name=Non-Hodgkin lymphoma, contentId=265612}, {keywordId=173600, uniqueName=cd19, name=CD19, contentId=265612}, {keywordId=327467, uniqueName=chimeric-antigen-receptors, last=true, name=chimeric antigen receptors, contentId=265612}],[{keywordId=52, uniqueName=immunotherapy, name=Immunotherapy, contentId=265612}, {keywordId=99, uniqueName=t-cells, name=T cells, contentId=265612}, {keywordId=15203, uniqueName=car-t-cell-therapy, name=CAR-T cell therapy, contentId=265612}, {keywordId=57082, uniqueName=non-hodgkin-lymphoma, name=Non-Hodgkin lymphoma, contentId=265612}, {keywordId=173600, uniqueName=cd19, name=CD19, contentId=265612}, {keywordId=327467, uniqueName=chimeric-antigen-receptors, last=true, name=chimeric antigen receptors, contentId=265612}],[{keywordId=52, uniqueName=immunotherapy, name=Immunotherapy, contentId=265612}, {keywordId=99, uniqueName=t-cells, name=T cells, contentId=265612}, {keywordId=15203, uniqueName=car-t-cell-therapy, name=CAR-T cell therapy, contentId=265612}, {keywordId=57082, uniqueName=non-hodgkin-lymphoma, name=Non-Hodgkin lymphoma, contentId=265612}, {keywordId=173600, uniqueName=cd19, name=CD19, contentId=265612}, {keywordId=327467, uniqueName=chimeric-antigen-receptors, last=true, name=chimeric antigen receptors, contentId=265612}],[{keywordId=52, uniqueName=immunotherapy, name=Immunotherapy, contentId=265612}, {keywordId=99, uniqueName=t-cells, name=T cells, contentId=265612}, {keywordId=15203, uniqueName=car-t-cell-therapy, name=CAR-T cell therapy, contentId=265612}, {keywordId=57082, uniqueName=non-hodgkin-lymphoma, name=Non-Hodgkin lymphoma, contentId=265612}, {keywordId=173600, uniqueName=cd19, name=CD19, contentId=265612}, {keywordId=327467, uniqueName=chimeric-antigen-receptors, last=true, name=chimeric antigen receptors, contentId=265612}],[{keywordId=52, uniqueName=immunotherapy, name=Immunotherapy, contentId=265612}, {keywordId=99, uniqueName=t-cells, name=T cells, contentId=265612}, {keywordId=15203, uniqueName=car-t-cell-therapy, name=CAR-T cell therapy, contentId=265612}, {keywordId=57082, uniqueName=non-hodgkin-lymphoma, name=Non-Hodgkin lymphoma, contentId=265612}, {keywordId=173600, uniqueName=cd19, name=CD19, contentId=265612}, {keywordId=327467, uniqueName=chimeric-antigen-receptors, last=true, name=chimeric antigen receptors, contentId=265612}],&subject=